Blog

Alan Ka-Lun Kai: Navigating EGFR resistance in the AsiaPac region

Alan Ka-Lun Kai/LinkedIn

Dec 5, 2024, 23:04

Alan Ka-Lun Kai: Navigating EGFR resistance in the AsiaPac region

Alan Ka-Lun Kai, Director, Head of Medical Affairs and Operation Excellence, posted the following on LinkedIn:

“EGFR resistance in lung cancer is an extremely important topic particularly in our AsiaPac region where the prevalence of EGFR is especially high compared to the rest of the world. It’s our great honour to have these highly scientific gentlemen Antonio Passaro, Herbert Loong, Molly Li, Nyaw Shi Feng to navigate the complexity of EGFR resistance with us together during IOHK. We are committed to transform patients’ lives further with you altogether.”

Alan Ka-Lun KAI Antonio Passaro AsiaPac region Cancer research EGFR resistance Herbert Loong IOHK Lung cancer lung cancer treatment Molly Li Nyaw Shi Feng OncoDaily Oncology patient transformation

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Eric Bouffet: New hope for children and adults with hemianopia

Devora Kestel: The official launch of the new WHO and UNICEF Service Guidance on Mental Health for Children and Young People

OncoThon 2024 Raises $1.3 Million for Pediatric Cancer Research

Special Coverage